Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
6.66
0.00 (0.00%)
At close: Aug 31, 2026, 4:00 PM EDT
6.66
0.00 (0.00%)
Pre-market: Sep 1, 2026, 5:24 AM EDT

Nuvation Bio Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
258.6164.0935.7242.65101.1132.42
Short-Term Investments
402.35365.13466.97568.56559.92632.97
Cash & Short-Term Investments
660.96529.21502.69611.21661.01765.39
Cash Growth
8.76%5.27%-17.76%-7.53%-13.64%254.76%
Accounts Receivable
27.8316.0812.72---
Other Receivables
3.893.293.573.72.493.04
Receivables
31.7119.3616.293.72.493.04
Inventory
19.911.41----
Prepaid Expenses
13.8611.547.271.523.823.64
Total Current Assets
726.43571.52526.26616.43667.32772.07
Property, Plant & Equipment
3.964.482.994.324.693.66
Other Intangible Assets
10.2911.214.62---
Other Long-Term Assets
3.827.616.760.730.140.42
Total Assets
744.5594.82540.63621.48672.14776.15

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
12.099.486.352.212.143.93
Accrued Expenses
45.244.932.159.659.711.74
Short-Term Debt
5.895.726.28---
Current Portion of Long-Term Debt
139.59----
Current Portion of Leases
1.721.881.661.971.210.86
Current Income Taxes Payable
-0.290.680.140.110.4
Current Unearned Revenue
8.867.5211.12---
Other Current Liabilities
-2.87----
Total Current Liabilities
86.7682.2358.2413.9713.1616.93
Long-Term Debt
393.7547.21----
Long-Term Leases
1.912.540.972.043.052.19
Long-Term Unearned Revenue
8.2311.3115.57---
Other Long-Term Liabilities
-145.822.050.350.8511.04
Total Liabilities
490.64289.1176.8416.3617.0730.15

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1,4291,4211,374947.75927.6909.99
Retained Earnings
-1,173-1,115-910.74-342.8-267-162.8
Comprehensive Income & Other
-2.61-0.190.570.18-5.53-1.19
Total Common Equity
253.86305.72463.79605.12655.08746
Shareholders' Equity
253.86305.72463.79605.12655.08746
Total Liabilities & Equity
744.5594.82540.63621.48672.14776.15

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
416.2666.948.924.014.263.06
Net Cash (Debt)
244.69462.27493.78607.21656.75762.34
Net Cash Growth
-39.49%-6.38%-18.68%-7.54%-13.85%253.34%
Net Cash Per Share
0.721.351.842.773.033.85
Filing Date Shares Outstanding
351.12347.6338.68219.05218.8219.06
Total Common Shares Outstanding
349.82346.5337.84219.05218.63217.95
Working Capital
639.68489.29468.01602.46654.16755.15
Book Value Per Share
0.730.881.372.763.003.42
Tangible Book Value
243.57294.5459.17605.12655.08746
Tangible Book Value Per Share
0.700.851.362.763.003.42
Machinery
-1.181.111.041.040.83
Construction In Progress
-0.03----
Leasehold Improvements
-0.540.350.340.320.24
SEC Filings: 10-K · 10-Q